Veradermics, Incorporated (MANE)
Veradermics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Veradermics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec '24 Dec '23
Debt / Equity Ratio
-0.01--0.04
Debt / EBITDA Ratio
-0.02--0.05
Debt / FCF Ratio
-0.02--0.06
Quick Ratio
2.6611.255.34
Interest Coverage
--253.69-
Return on Equity (ROE)
56.04%54.64%74.14%
Return on Assets (ROA)
--47.70%-93.90%
Return on Capital Employed (ROCE)
955.06%-51.92%-119.39%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).